Armen Karamanian

Eliksa Therapeutics

Armen is the managing director of Admire Capital, a systematic value and activist hedge fund.

He completed his Kauffman Fellowship at Karlin Asset Management, a private investment firm with $1.3+ billion under management. At Karlin, he focused on researching, executing and monitoring quantitative investment strategies for private and publicly traded companies.

Education, Personal, and Fellowship

He holds a PhD from the University of Pennsylvania and received entrepreneurial training at The Wharton School.

Armen is a member of Class 15. He served his fellowship at Karlin Asset Management under the mentorship of the firm's CEO, David Cohen.